Based in Barcelona, Solchem was founded in 1994 to distribute raw materials for the dietary sector. The company later expanded its portfolio to include a wide range of premium ingredients and formulations for the nutraceutical market. With a team of 14 staff members, Solchem brings an extensive nutraceutical portfolio to the Iberian market. Backed by long-standing relationships with well-known principals in the industry, it is a valuable contribution to Azelis’s lateral value chain. The acquis...

Epsilogen, the global leader in the development of immunoglobulin E (IgE) antibody therapeutics, today announces that it has completed the acquisition of TigaTx, Inc., a biotechnology company developing engineered immunoglobulin A (IgA) antibodies, to create the world’s leading pan-isotype cancer antibody company. As a result of the combination of these two privately held companies, US-based TigaTx becomes a wholly owned subsidiary of Epsilogen. Financial terms of the transaction have not been...